In the world of medical advancements, 3D-printed organs have made a significant stride. Latest trials have demonstrated that these bioengineered organs can maintain their function for up to six months ...

Recent years have seen a swift expansion of the 3D bioprinted human tissue market, which is projected to rise from $1.70 billion in 2024 to $1.93 billion in 2025, exhibiting a compound annual growth ...

Science writer Mary Roach chronicles both the history and the latest science of body part replacement in her new book. She ...

Scientists have achieved a major breakthrough by 3D bioprinting miniature placentas, providing a new way to study pregnancy complications.

In April 2025, the US Food and Drug Administration (FDA) announced a pivotal shift in drug development policy. The agency has set out to reduce, refine and potentially replace its long-standing ...

This breakthrough combines 3D bioprinting, organoid technology, and placental research. It may pave the way for safer drugs, ...

Tencent launches Hunyuan 3D 3.0 with 3× precision, 36B voxels, better character modeling, improved textures, and free public ...

Spheroids Market revenue is expected to grow at a CAGR of 23.3% from 2025 to 2032, reaching nearly USD 4183.33 Mn by 2032. Spheroids are no longer just lab models, they’re catalysts accelerating drug ...

MIT and collaborators have developed "Fetal SMPL," a machine-learning tool providing 3D representations of fetal development.

Traditional animal models and simplified cell cultures often fail to capture human biology, limiting progress in biomedical research and drug development. Emerging microfluidic "Organ-on-Chip" ...

Organoids have emerged as a groundbreaking technology in cell biology, offering a three-dimensional culture system that ...